IN8bio Inc.
Last updated September 27, 2026
Organization details
- Legal name
- IN8bio Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- INAB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001740279
Board of directors
-
Alan S. Roemer · DirectorSince 2023
-
Corinne Epperly · DirectorSince 2023
-
Emily Fairbairn · DirectorSince 2023
-
Jeremy R. Graff · DirectorSince 2023
-
Luba Greenwood · DirectorSince 2023
-
Peter C. Brandt · DirectorSince 2023
-
Travis Whitfill · DirectorSince 2023
-
William Tai-Wei Ho · Director · CEOSince 2023
Chief executives
William Tai-Wei Ho
· President and CEO
Dates unknown
Board connections
3 of this board's directors also sit on 3 other boards.
- via Travis Whitfill
- via Emily Fairbairn
- via Luba Greenwood
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2026 | Emily Fairbairn Director | Gift | −724,637 | — | — |
| Dec 22, 2025 | Rochlin Kate Officer (Chief Operating Officer) | Grant or award | +7,247 | $1.38 | $10,001 |
| Dec 22, 2025 | McCall Patrick Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +7,247 | $1.38 | $10,001 |
| Dec 22, 2025 | William Tai-Wei Ho Director, Officer (PRESIDENT AND CEO), 10% owner | Grant or award | +36,232 | $1.38 | $50,000 |
| Dec 22, 2025 | Alan S. Roemer Director | Grant or award | +36,232 | $1.38 | $50,000 |
| Dec 22, 2025 | Peter C. Brandt Director | Grant or award | +72,464 | $1.38 | $100,000 |
| Dec 22, 2025 | Emily Fairbairn Director | Grant or award | +724,637 | $1.38 | $999,999 |
| Apr 30, 2025 | Rochlin Kate Officer (Chief Operating Officer) | Option exercise | +12,295 | $0.18 | $2,213 |
| Apr 30, 2025 | McCall Patrick Officer (CHIEF FINANCIAL OFFICER) | Option exercise | +15,000 | $0.18 | $2,700 |
| Apr 30, 2025 | Alan S. Roemer Director | Option exercise | +102,459 | $0.18 | $18,443 |
| Apr 30, 2025 | Peter C. Brandt Director | Option exercise | +81,967 | $0.18 | $14,754 |
| Apr 30, 2025 | Alan S. Roemer Director | Option exercise | +11,000 | $0.18 | $1,980 |
| Apr 30, 2025 | Peter C. Brandt Director | Option exercise | +81,967 | $0.18 | $14,754 |
| Oct 4, 2024 | Rochlin Kate Officer (Chief Operating Officer) | Grant or award | +25,316 | — | — |
| Oct 4, 2024 | McCall Patrick Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +25,316 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.